TrialSignal
Clinical trial intelligence report
Virtual Seating Coach on Power Wheelchairs of Persons With ALS
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 25, 2026
Report code
NCT05742828-Jun 25, 2026
NCT ID
NCT05742828
Status
COMPLETED
Phase
Completed
Sponsor
Wake Forest University Health Sciences
Executive brief
Investment-Ready Snapshot
The Virtual Seating Coach (VSC) is positioned to enhance the quality of life for ALS patients by improving wheelchair functionality and reducing the incidence of pressure injuries and associated pain. Given the increasing prevalence of ALS and the aging population, there is a significant market opportunity for assistive technologies that improve patient care. The collaboration with Permobil, Inc. suggests a strategic partnership that could facilitate market penetration and reimbursement pathways, despite current insurance coverage limitations. The findings from this study may provide valuable data to support future reimbursement negotiations and expand the clinical use of VSC in similar patient populations, potentially leading to a competitive advantage in the assistive technology market.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05742828
Indication
Amyotrophic Lateral Sclerosis
Modality
behavioral intervention
Target
Virtual Seating Coach (VSC) for pressure injury management and pain reduction in ALS patients using power wheelchairs.
Intervention
Virtual Seating Coach
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.